重型抑郁癥(MDD)治療藥 沃替西汀(vortioxetine)是治療抑郁癥的新藥,由丹麥靈北制藥(Lundbeck)和日本武田制藥(Takeda)聯(lián)合研發(fā),于2013年9月30日由美國食品藥品監(jiān)督管理局(FDA)批準(zhǔn)上市,商品名Brintellix,用于重型抑郁癥(MDD)的治療。
Vortioxetine is used to cure depression as a new drug, it was co-developmented by Lundbeck and Takeda, and it was approveled by FDA on September, 30, 2013. Business name is Brintellix, for the treatment of major depressive disorder.
上海清松制藥有限公司
聯(lián)系商家時(shí)請(qǐng)?zhí)峒癱hemicalbook,有助于交易順利完成!